Literature DB >> 3032044

Thrombin-cellular interactions.

M A Shuman.   

Abstract

It is clear that there are a number of different types of reactions between thrombin and the cell surface (TABLE 6). In one type, thrombin binds to cell-surface receptors resulting in cellular activation. In other types of reactions, there are at least two components to the thrombin-specific pathway of cellular activation: a classical receptor to which thrombin binds, and a protein that is cleaved. In both types of reactions, thrombin binding and/or proteolysis is linked to changes in GTP-binding proteins, protein kinase C, or other pathways. In most cases, the receptor and membrane substrates involved in cellular activation are not well characterized. In another type of reaction, the interaction between thrombin and proteins in the extracellular fluid is regulated by cell-surface receptors. Binding of thrombin to these receptors can result in acceleration or inhibition of the reactions with the soluble proteins. In the fourth type of reaction, thrombin cleaves a cell-membrane protein that is involved in reactions with plasma proteins. Recognition of the different types of interactions between thrombin and the cell surface is necessary for the correct interpretation of experimental observations. Although the term receptor has classically referred to a cell-surface component to which an agonist binds, it is now clear that there are additional membrane components that specifically bind potential agonists not leading to cellular activation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3032044     DOI: 10.1111/j.1749-6632.1986.tb34585.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  33 in total

Review 1.  Characterization of a functional thrombin receptor. Issues and opportunities.

Authors:  S R Coughlin; T K Vu; D T Hung; V I Wheaton
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

2.  Inducible release of an endothelial cell-specific protein.

Authors:  C W Carson; G G Hunder; K L Kaplan; C M Johnson
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

3.  Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury.

Authors:  J T Willerson; S K Yao; J McNatt; C R Benedict; H V Anderson; P Golino; S S Murphree; L M Buja
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

4.  Effects of thrombin on single calcium channels in frog ventricular cells.

Authors:  F Markwardt; T Franke; R Albitz; B Nilius
Journal:  Pflugers Arch       Date:  1990-02       Impact factor: 3.657

5.  Functional expression of a human thrombin receptor in Sf9 insect cells: evidence for an active tethered ligand.

Authors:  X Chen; K Earley; W Luo; S H Lin; W P Schilling
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

6.  Functional analysis of the human tissue factor promoter and induction by serum.

Authors:  N Mackman; B J Fowler; T S Edgington; J H Morrissey
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

7.  Identification of a synthetic nonapeptide sequence that inhibits motility in culture of a melanoma subclone that possesses a high metastatic potential.

Authors:  B S Packard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

8.  Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.

Authors:  S R Hanson; J H Griffin; L A Harker; A B Kelly; C T Esmon; A Gruber
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide A.

Authors:  B E Maryanoff; X Qiu; K P Padmanabhan; A Tulinsky; H R Almond; P Andrade-Gordon; M N Greco; J A Kauffman; K C Nicolaou; A Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

Review 10.  Coagulation disorders in septic shock.

Authors:  L G Thijs; J P de Boer; M C de Groot; C E Hack
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.